Regeneron Pharmaceuticals, Inc. Financial Ratios — REGN

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	118.94	68.85	51.05	59.61	33.49	38.45	54.09	20.52	15.64	14.97	13.35
Return on Assets (%)	-18.38	44.08	16.45	9.96	13.47	14.23	15.23	23.85	15.94	21.98	37.91	15.88	12.69	12.46	11.5
Return on Capital (%)	- -	- -	249.84	65.24	68.08	52.27	41.26	51.42	30.48	32.89	46.09	18.42	14.37	13.87	12.47
Return on Invested Capital (%)	- -	- -	21.22	13.39	18.5	19.51	19.96	29.71	18.04	25.77	43.84	17.94	14.1	12.09	9.58
Gross Margin (%)	99.05	93.87	92.62	92.73	90.43	93.83	93.24	91.89	88.33	86.82	84.83	87.18	86.16	86.13	85.35
EBITDA Margin (%)	-39.05	35.88	37.26	31.09	32.33	29.53	37.89	52.13	36.91	44.87	57.75	41.73	34.06	31.5	29.6
Operating Margin (%)	-46.02	33.2	35.3	29.22	30.51	27.38	35.41	49.25	33.7	42.09	55.97	38.93	30.85	28.1	25.81
Incremental Operating Margin (%)	- -	71.07	39.29	11.31	33.33	10.41	74.02	-62.59	-22.99	70.47	71.53	109.16	-73.26	-5.2	-204.9
Pretax Margin (%)	-50	30.06	33.09	27	29.85	27.36	35.4	49.62	37.04	44.84	58.03	39.91	32.01	33.66	36.47
Profit Margin (%)	-49.74	54.43	19.66	11.99	15.5	18.42	20.41	47.5	32.26	41.35	50.25	35.64	30.14	31.07	31.41
Net Income to Common Margin (%)	-49.74	54.43	19.66	11.99	15.5	18.42	20.41	47.5	32.26	41.35	50.25	35.64	30.14	31.07	31.41
Effective Tax Rate (%)	- -	- -	40.59	55.58	48.08	32.66	42.34	4.27	12.9	7.8	13.41	10.71	5.85	7.68	13.88
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.22
Sustainable Growth Rate (%)	- -	- -	- -	- -	118.94	68.85	51.05	59.61	33.49	38.45	54.09	20.52	15.64	14.97	12.26

Credit (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	436	457	506	458	363	481	704	708	714	2,696	2,700	2,701	2,703	2,704	2,706
ST Debt	1	1	1	- -	- -	130	- -	- -	- -	- -	720	- -	- -	- -	- -
LT Debt	435	456	505	458	363	352	704	708	714	2,696	1,980	2,701	2,703	2,704	2,706
Total Debt/EBITDA	-2.5	0.92	0.64	0.52	0.27	0.34	0.32	0.26	0.29	0.71	0.29	0.53	0.6	0.6	0.64
Net Debt/EBITDA	1.2	0.13	-0.27	-0.57	-0.61	-0.37	-0.37	-0.55	-0.67	-0.06	-0.1	-0.22	-0.17	-0.11	-0.27
Total Debt/EBIT	-2.12	1	0.68	0.56	0.29	0.36	0.34	0.28	0.32	0.75	0.3	0.57	0.67	0.68	0.73
Net Debt/EBIT	1.02	0.14	-0.29	-0.61	-0.65	-0.4	-0.39	-0.58	-0.73	-0.06	-0.1	-0.24	-0.18	-0.13	-0.31
EBITDA to Interest Expense	-8.18	10.92	16.89	23.46	93.17	199.36	88.65	95.13	80.14	67	161.97	85.53	61.21	81.04	96.93
EBITDA-CapEx/Interest Expense	-8.18	10.92	16.89	23.46	93.17	199.36	88.65	95.13	80.14	67	161.97	68.24	58.36	78.77	89.74
EBIT to Interest Expense	-9.64	10.1	16	22.05	87.91	184.82	82.85	89.87	73.17	62.86	156.98	79.78	55.44	72.3	84.52
Interest Expense	21	45	46	37	14	7	25	28	30	57	57	59	73	55	44
Common Equity/Total Assets	-95.74	-24.85	-3.14	5.65	15.2	25.07	33.62	44.78	49.85	63.47	74.58	79.78	82.41	83.88	88.26
Long-Term Debt/Equity (%)	89.46	36.61	25.85	17.95	9.93	7.9	11.45	8.09	6.44	24.45	10.55	11.92	10.41	9.21	8.66
Long-Term Debt/Capital (%)	-52.25	-764.65	122.2	67.86	29.85	15.77	19.27	11.88	8.82	19.84	9.14	10.39	9.02	7.87	7.03
Long-Term Debt/Total Assets (%)	32.83	21.92	17.1	11.93	6.47	5.04	8.03	6.04	4.82	15.71	7.78	9.25	8.17	7.16	6.67
Total Debt/Equity (%)	89.67	36.72	25.9	17.95	9.93	10.81	11.45	8.09	6.44	24.45	14.38	11.92	10.41	9.21	8.66
Total Debt/Capital (%)	-52.37	-766.96	122.42	67.86	29.85	21.58	19.27	11.88	8.82	19.84	12.46	10.39	9.02	7.87	7.03
Total Debt/Total Assets (%)	32.91	21.98	17.13	11.93	6.47	6.9	8.03	6.04	4.82	15.71	10.61	9.25	8.17	7.16	6.67
Net Debt to Equity	-42.94	5.32	-11.03	-19.68	-22.14	-12.03	-13.23	-16.76	-14.59	-1.95	-4.83	-4.96	-2.88	-1.72	-3.62
Net Debt/Capital (%)	15.86	-22.85	175.48	-1,950.06	-198.98	-31.59	-28.64	-32.65	-24.98	-1.89	-4.82	-4.91	-2.74	-1.58	-3.2
EBITDA	-174	495	784	877	1,327	1,435	2,225	2,683	2,420	3,812	9,281	5,080	4,468	4,474	4,246
EBITDA-CapEx	-174	495	784	877	1,327	1,435	2,225	2,683	2,420	3,812	9,281	4,054	4,260	4,348	3,930
Operating Income (Loss)	-205	458	743	824	1,252	1,331	2,080	2,534	2,210	3,577	8,995	4,739	4,047	3,991	3,702

Liquidity (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.55	1.88	2.32	1.38	1.29	0.84	1.24	1.95	1.53	1.33	1.45	2.46	3.17	2.28	1.97
Current Ratio	4.49	7.37	6.01	3.18	3.59	2.56	3.82	4.47	3.67	3.63	3.56	5.06	5.69	4.73	4.13
Quick Ratio	4.25	6.12	5.52	2.87	3.1	2.13	2.98	3.5	2.86	2.86	2.98	4.16	4.82	3.86	3.28
CFO/Avg Current Liab	-1.1	-0.48	2.55	1.58	1.82	1.45	1.1	1.7	1.37	1.09	2.14	1.42	1.4	1.2	1.2
Common Equity/Total Assets	-95.74	-24.85	-3.14	5.65	15.2	25.07	33.62	44.78	49.85	63.47	74.58	79.78	82.41	83.88	88.26
Long-Term Debt/Equity (%)	89.46	36.61	25.85	17.95	9.93	7.9	11.45	8.09	6.44	24.45	10.55	11.92	10.41	9.21	8.66
Long-Term Debt/Capital (%)	-52.25	-764.65	122.2	67.86	29.85	15.77	19.27	11.88	8.82	19.84	9.14	10.39	9.02	7.87	7.03
Long-Term Debt/Total Assets (%)	32.83	21.92	17.1	11.93	6.47	5.04	8.03	6.04	4.82	15.71	7.78	9.25	8.17	7.16	6.67
Total Debt/Equity (%)	89.67	36.72	25.9	17.95	9.93	10.81	11.45	8.09	6.44	24.45	14.38	11.92	10.41	9.21	8.66
Total Debt/Capital (%)	-52.37	-766.96	122.42	67.86	29.85	21.58	19.27	11.88	8.82	19.84	12.46	10.39	9.02	7.87	7.03
Total Debt/Total Assets (%)	32.91	21.98	17.13	11.93	6.47	6.9	8.03	6.04	4.82	15.71	10.61	9.25	8.17	7.16	6.67
CFO/Total Liabilities	-16.91	-8.93	58.92	58.45	68.1	58.87	49.89	73.73	65.4	42.65	106.23	76.56	64.64	52.59	53.53
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.88	22.11	35.17	15.79
Altman's Z-Score	2.55	13.28	18.3	21.21	19.31	11.15	11.52	10.41	8.71	7.65	9.33	9.75	10.53	7.93	7.58

Working Capital (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.82	3.46	2.55	2.92	3.36	3.16	3.28	2.44	2.85	2.62	3.17	2.14	2.39	2.39	2.4
Days Sales Outstanding	75.71	105.4	142.9	125.01	108.7	115.63	111.45	149.58	128.13	139.08	115.27	170.39	152.99	152.65	152.09
Inventory Turnover	0.47	3.73	3.14	2.06	2.14	0.94	0.71	0.44	0.6	0.67	1.26	0.72	0.73	0.7	0.67
Days Inventory Outstanding	780.78	97.79	116.29	177.33	170.76	388.46	517.24	820.62	612.24	543	289.6	509.14	500.76	524.93	546.28
Accounts Payable Turnover	0.9	2.89	3.91	3.26	4.18	3.34	4.62	4.25	3.24	3.63	4.76	3.49	3.34	3.55	2.56
Accounts Payable Turnover Days	407.42	126.11	93.41	111.81	87.35	109.36	78.96	85.86	112.81	100.61	76.74	104.65	109.42	102.85	142.47
Cash Conversion Cycle	449.07	77.08	165.78	190.54	192.11	394.73	549.72	884.34	627.55	581.47	328.13	574.87	544.33	574.73	555.91
Inventory to Cash Days	-705.07	7.62	26.61	-52.33	-62.06	-272.84	-405.79	-671.03	-484.11	-403.93	-174.33	-338.75	-347.78	-372.28	-394.19
Inventories	17	29	70	129	239	399	726	1,151	1,416	1,917	1,951	2,402	2,580	3,087	3,201
Raw Materials	5	5	9	11	59	92	190	227	216	459	722	818	789	880	642
Work In Process	9	15	36	74	132	202	302	571	728	905	707	963	1,122	1,342	1,642
Finished Goods	1	3	14	11	11	13	22	24	71	122	74	99	147	140	190
Other Inventory	2	7	11	34	36	91	212	329	401	431	448	522	522	726	728

Enterprise Value (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	5,023	16,198	26,951	41,276	55,949	38,441	39,979	40,301	41,002	51,983	66,752	77,272	93,714	76,860	80,738
- Cash & Cash Equivalents	484	230	536	649	809	535	813	1,468	1,618	2,194	2,886	3,106	2,730	2,488	3,118
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	436	457	506	458	363	481	704	708	714	2,696	2,700	2,701	2,703	2,704	2,706
Enterprise Value	4,931	16,347	26,762	40,833	55,266	37,884	39,273	38,199	38,502	51,091	63,757	72,231	85,572	70,552	74,838
Total Capital	-832	-60	413	674	1,216	2,229	3,650	5,963	8,094	13,589	21,668	26,008	29,963	34,377	38,503
Total Debt/Capital (%)	-52.37	-766.96	122.42	67.86	29.85	21.58	19.27	11.88	8.82	19.84	12.46	10.39	9.02	7.87	7.03
Total Debt / EV	0.09	0.03	0.02	0.01	0.01	0.01	0.02	0.02	0.02	0.05	0.04	0.04	0.03	0.04	0.04
EV/Sales	11.06	11.86	12.72	14.48	13.47	7.79	6.69	7.42	5.87	6.01	3.97	5.93	6.52	4.97	5.22
EV/EBITDA	- -	33.05	34.12	46.58	41.65	26.39	17.65	14.24	15.91	13.4	6.87	14.22	19.15	15.77	17.63
EV/EBIT	- -	35.71	36.02	49.56	44.15	28.47	18.88	15.07	17.42	14.28	7.09	15.24	21.14	17.68	20.22
EV/Cash Flow to Firm	- -	2,208.01	43.43	53.1	41.3	25.41	29.72	17.19	15.67	19.13	8.94	14.25	18.35	15.78	14.92
EV/Free Cash Flow to Firm	- -	2,208.01	43.43	53.1	41.3	25.41	29.72	17.19	15.67	19.13	8.94	11.85	17.57	15.35	14.04
Diluted Market Cap	5,023	19,738	30,631	46,528	62,555	42,717	43,594	42,878	43,030	55,606	70,857	81,889	99,862	81,989	83,825
Diluted Enterprise Value	4,974	19,965	30,601	46,337	62,109	42,663	43,485	42,119	42,126	56,108	70,671	81,485	99,834	82,205	83,413
EV per Share	54.42	172.65	273.32	405.85	536.25	361.77	369.32	354.02	352.58	474.83	603.19	674.42	801.98	653.87	715.47
TTM Sales	446	1,378	2,105	2,820	4,104	4,860	5,872	5,146	6,558	8,497	16,072	12,173	13,117	14,202	14,343
TTM EBITDA	-174	495	784	877	1,327	1,435	2,225	2,683	2,420	3,812	9,281	5,080	4,468	4,474	4,246
TTM Operating Income	-205	458	743	824	1,252	1,331	2,080	2,534	2,210	3,577	8,995	4,739	4,047	3,991	3,702
TTM Cash Flow to Firm	-121	7	616	769	1,338	1,491	1,322	2,222	2,456	2,671	7,131	5,068	4,663	4,471	5,017
TTM Free Cash Flow to Firm	-121	7	616	769	1,338	1,491	1,322	2,222	2,456	2,671	7,131	6,095	4,871	4,597	5,332

Multiples (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-35.45	-264.54	52.04	61.84	47.01	28.75	33.35	19.53	17.71	21.24	10.01	13.55	20.8	18.03	15.83
EV/EBIT	- -	35.71	36.02	49.56	44.15	28.47	18.88	15.07	17.42	14.28	7.09	15.24	21.14	17.68	20.22
Enterprise Value	4,931	16,347	26,762	40,833	55,266	37,884	39,273	38,199	38,502	51,091	63,757	72,231	85,572	70,552	74,838
Low Price	32.32	56.01	154.16	262.97	393	325.35	340.09	281.89	271.37	328.13	441	538.01	668	693	476.49
EV/Sales	11.06	11.86	12.72	14.48	13.47	7.79	6.69	7.42	5.87	6.01	3.97	5.93	6.52	4.97	5.22
EV/EBITDA	- -	33.05	34.12	46.58	41.65	26.39	17.65	14.24	15.91	13.4	6.87	14.22	19.15	15.77	17.63
Price/Earnings	- -	21.59	65.14	122.07	87.96	42.93	33.36	16.49	19.38	14.8	8.27	17.81	23.7	17.42	17.92
Price/Earnings Average	-20.88	16.51	56.77	99.29	80.81	46.13	37.49	15.52	17.73	16.3	7.31	16.36	21.15	23.68	14.44
Price/Earnings High	-32.65	23.85	75.69	130.22	98.18	62.32	48.23	18.38	22.81	20.36	8.99	19.23	24.29	29.62	18.41
Price/Earnings Low	-13.21	7.07	36.48	78.25	63.68	38.05	30.17	12.44	14.01	10.05	5.77	13.28	18.03	16.95	11.06
Price/Book Value	-3.96	-31.33	-291.07	190.43	65.61	21.99	13.57	7.67	5.56	4.77	3.52	3.32	3.44	2.43	2.26
Price/Book Value Average	-3.65	-23.96	-253.65	154.88	60.27	23.63	15.25	7.22	5.08	5.26	3.11	3.04	3.07	3.3	1.82
Price/Book Value High	-5.71	-34.61	-338.22	203.15	73.23	31.92	19.61	8.55	6.54	6.57	3.83	3.58	3.52	4.13	2.32
Price/Book Value Low	-2.31	-10.26	-163.02	122.07	47.49	19.49	12.27	5.79	4.02	3.24	2.46	2.47	2.61	2.36	1.39
Price/Tangible Book Value	10.34	13.01	13.81	16.19	15.31	8.64	6.51	4.6	3.7	4.71	3.56	3.55	3.76	2.73	2.69
Price/Tangible Book Value Average	9.53	9.95	12.03	13.16	14.06	9.29	7.31	4.33	3.38	5.2	3.15	3.26	3.35	3.7	2.17
Price/Tangible Book Value High	14.9	14.37	16.04	17.27	17.09	12.54	9.41	5.13	4.35	6.49	3.87	3.84	3.85	4.63	2.76
Price/Tangible Book Value Low	6.03	4.26	7.73	10.37	11.08	7.66	5.89	3.47	2.67	3.2	2.48	2.65	2.86	2.65	1.66
Price/Sales	11.27	11.75	12.8	14.64	13.63	7.91	6.81	7.83	6.25	6.12	4.15	6.35	7.14	5.41	5.63
Price/Sales Average	10.39	8.99	11.16	11.91	12.53	8.5	7.65	7.37	5.72	6.74	3.67	5.83	6.38	7.36	4.54
Price/Sales High	16.24	12.98	14.88	15.62	15.22	11.48	9.84	8.73	7.36	8.42	4.52	6.85	7.32	9.2	5.78
Price/Sales Low	6.57	3.85	7.17	9.38	9.87	7.01	6.16	5.91	4.52	4.16	2.9	4.73	5.43	5.27	3.47
Price/Cash Flow	-35.45	-217.08	45.79	54.86	42.04	25.87	30.59	18.36	16.87	19.86	9.43	15.41	20.4	17.39	16.22
Price/Cash Flow Average	-32.68	-166.03	39.9	44.62	38.62	27.8	34.37	17.29	15.44	21.88	8.33	14.15	18.21	23.64	13.07
Price/Cash Flow High	-51.1	-239.77	53.21	58.52	46.93	37.56	44.22	20.47	19.86	27.32	10.25	16.64	20.9	29.56	16.66
Price/Cash Flow Low	-20.67	-71.08	25.65	35.16	30.44	22.93	27.67	13.86	12.19	13.49	6.58	11.49	15.51	16.92	10.01
Price/Free Cash Flow Average	-32.68	-202.32	45.35	50.29	43.18	30.89	37.48	18.39	16.2	23.4	8.85	12.45	18.56	24.52	12.76
Price/Free Cash Flow High	-51.1	-292.19	60.47	65.96	52.47	41.73	48.22	21.78	20.84	29.22	10.88	14.63	21.31	30.66	16.26
Price/Free Cash Flow Low	-20.67	-86.61	29.15	39.64	34.03	25.48	30.17	14.74	12.8	14.43	6.99	10.11	15.82	17.55	9.77
EV/Sales Average	10.28	9.15	11.14	11.84	12.42	8.49	7.63	7.23	5.58	6.8	3.66	5.8	6.37	7.37	4.51
EV/Sales High	16.13	13.14	14.86	15.55	15.11	11.47	9.82	8.59	7.22	8.48	4.5	6.82	7.32	9.22	5.75
EV/Sales Low	6.46	4.01	7.16	9.32	9.76	7	6.14	5.76	4.38	4.21	2.89	4.7	5.43	5.28	3.45
EV/EBITDA Average	-26.33	25.5	29.91	38.08	38.4	28.74	20.14	13.86	15.13	15.16	6.34	13.89	18.71	23.4	15.23
EV/EBITDA High	-41.31	36.63	39.89	50.01	46.73	38.84	25.93	16.47	19.57	18.89	7.8	16.34	21.48	29.26	19.43
EV/EBITDA Low	-16.55	11.18	19.21	29.96	30.19	23.7	16.2	11.06	11.87	9.39	5	11.26	15.95	16.76	11.64
EV/EBIT Average	-22.34	27.56	31.57	40.51	40.7	31	21.55	14.67	16.57	16.16	6.54	14.89	20.66	26.23	17.47
EV/EBIT High	-35.05	39.58	42.11	53.21	49.53	41.9	27.74	17.43	21.43	20.14	8.05	17.52	23.72	32.8	22.29
EV/EBIT Low	-14.04	12.08	20.27	31.88	32	25.56	17.34	11.7	13	10.01	5.16	12.07	17.6	18.79	13.35
Last Price	55.43	171.07	275.24	410.25	542.87	367.09	375.96	373.5	375.48	483.11	631.52	721.49	878.29	712.33	771.87
High Price	79.9	188.95	319.83	437.64	605.93	532.91	543.55	416.49	442	664.64	686.62	779	899.86	1,211.2	792.77
Enterprise Value Average	4,583	12,615	23,456	33,380	50,954	41,258	44,817	37,186	36,607	57,784	58,829	70,551	83,607	104,695	64,659
Enterprise Value High	7,192	18,118	31,287	43,841	62,002	55,752	57,691	44,180	47,363	72,017	72,390	83,026	95,988	130,905	82,512
Enterprise Value Low	2,880	5,530	15,065	26,267	40,057	34,016	36,055	29,657	28,730	35,809	46,428	57,216	71,248	74,991	49,429

Shares Outstanding	93	97	100	102	105	106	108	109	110	107	109	110	109	110	106
Diluted Weighted Avg Shares	91	115	111	113	115	116	116	115	115	115	112	114	114	115	109
Basic Weighted Avg Shares	91	95	98	101	103	105	106	108	109	108	106	107	107	108	105
Revenue per Share	4.92	14.56	21.5	28.02	39.82	46.41	55.22	47.69	60.05	78.97	152.05	113.66	122.94	131.62	137.12
EBITDA per Share	-1.92	5.22	8.01	8.71	12.87	13.71	20.92	24.86	22.16	35.43	87.81	47.44	41.88	41.46	40.59
Operating Income per Share	-2.26	4.83	7.59	8.19	12.15	12.71	19.56	23.49	20.24	33.24	85.1	44.25	37.93	36.99	35.39
Basic EPS, GAAP	-2.45	7.92	4.23	3.36	6.17	8.55	11.27	22.65	19.38	32.65	76.4	40.51	37.05	40.9	43.07
Basic EPS from Cont Ops	-2.45	7.92	4.23	3.36	6.17	8.55	11.27	22.65	19.38	32.65	76.4	40.51	37.05	40.9	43.07
Diluted EPS, GAAP	-2.45	6.5	3.72	2.98	5.52	7.7	10.34	21.29	18.46	30.52	71.97	38.22	34.77	38.34	41.48
Diluted EPS from Cont Ops	-2.45	6.5	3.72	2.98	5.52	7.7	10.34	21.29	18.46	30.52	71.97	38.22	34.77	38.34	41.48
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.54
Cash Flow per Share	-1.56	-0.79	6.01	7.48	12.91	14.19	12.29	20.34	22.25	24.33	66.99	46.82	43.06	40.97	47.6
Free Cash Flow per Basic Share	-1.56	-0.79	6.01	7.48	12.91	14.19	12.29	20.34	22.25	24.33	66.99	37.24	41.11	39.8	44.59
Cash & Equivalents per Share	5.82	3.25	7.09	8.95	10.14	9.92	13.25	26.04	29.43	33.34	53.88	72.29	101.64	83.53	82.27
Book Value per Share	-13.99	-5.46	-0.95	2.15	8.27	16.7	27.71	48.7	67.58	101.24	179.46	217.62	255.49	293.54	342.23
Tangible Book Value per Share	5.36	13.15	19.94	25.35	35.46	42.49	57.78	81.16	101.55	102.47	177.5	203.07	233.69	261.4	286.8

Regeneron Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)